The global pelvic floor stimulators market is on the cusp of significant growth, with the market expected to reach USD 325.41 million by 2033 from its current value of USD 140.39 million in 2023, according to a recent report by Future Market Insights (FMI). This impressive growth represents a Compound Annual Growth Rate (CAGR) of 8.8% over the next decade.
Pelvic floor stimulators are becoming an essential tool in the management of various urological conditions, including cystitis, urinary retention, kidney stones, and benign prostatic hyperplasia. These devices, which provide non-invasive therapeutic solutions, are increasingly favored by both healthcare providers and patients for their effectiveness in improving quality of life for individuals dealing with such disorders.
A key driver of this growing demand is the aging global population and the rising prevalence of urological disorders worldwide. As the population ages, the need for effective management of these conditions is becoming more pressing.
The Asia Pacific region is emerging as a significant growth area for the pelvic floor stimulators market. Countries such as China, India, and Japan are seeing rising demand, fueled by the expanding elderly population and increased awareness of urological health issues. This region’s potential is expected to make it a key player in the global market’s growth trajectory.
“As the global population ages, there is an urgent need for effective solutions to manage urological disorders,” said a representative from Future Market Insights. “Pelvic floor stimulators offer a non-invasive, therapeutic approach, making them increasingly popular among healthcare providers and patients alike.”
With sustained innovation and investment, the pelvic floor stimulators market is poised to continue its upward trend, providing significant benefits to both patients and the healthcare industry. The report underlines the growing importance of addressing urological health issues with advanced, patient-friendly technologies, setting the stage for continued market expansion in the coming years.
Key findings from the FMI report include:
- The global pelvic floor stimulators market is expected to reach USD 325.41 million by 2033, with a robust CAGR of 8.8%.
- Pelvic floor stimulators address the growing need for effective treatments for urological conditions such as cystitis, urinary retention, and benign prostatic hyperplasia.
- An increasing geriatric population is a major factor driving market growth, particularly in regions with high elderly population density.
- Countries like China, India, and Japan are experiencing a significant rise in demand due to a growing elderly population and increased awareness of urological issues.
Industry Innovations and Strategic Moves:
To bolster their market presence, companies are focusing on technological advancements and strategic acquisitions. Recent developments include:
- Product Launch: Zynex, a leading electrotherapy devices manufacturer, launched NeuroMove in February 2018. This product is designed to assist stroke survivors in regaining movement through neuroplasticity.
- Acquisition: Laborie, a prominent medical technology company, acquired Clinical Innovations in February 2020 for USD 525 million, aiming to strengthen its market position.
Soaring Demand for Market Information: Uncover Detailed Trends and Insights in Our Report!
Key Players in the Market:
- Medtronic Plc
- Atlantic Therapeutics
- Laborie Inc.
- The Prometheus Group
- Everyway Medical Instruments Co., Ltd.
- KayCo 2 Ltd.
- InControl Medical Ltd.
- Tic Medizintechnik GmbH
- Shenzhen XFT Medical Ltd.
- Chiaro Technology Ltd.
- Zynex Inc.
- Utah Medical Products, Inc.
- Verity Medical Ltd.
Market Segmentation:
- Product Type: Electrical Stimulators, Magnetic Stimulators
- Application: Urinary Incontinence, Sexual Dysfunction, Neurodegenerative Diseases
- End User: Hospitals, Ambulatory Surgical Centers, Specialized Clinics, Homecare Settings
- Region: North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East and Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube